GLOBUS MEDICAL INC

For the period ended Dec 31, 2023. Filed Feb 21, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 21, 2024

GMED$76.37+7.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,	December 31,
(In thousands, except share and per share values)	2023	2022
ASSETS
Current assets:
Cash and cash equivalents	$467,292	$150,466
Short-term marketable securities	50,497	295,592
Accounts receivable, net of allowances of $8,934 and $4,724, respectively	503,235	213,247
Inventories	848,135	298,981
Prepaid expenses and other current assets	44,580	20,997
Income taxes receivable	1,635	4,061
Total current assets	1,915,374	983,344
Property and equipment, net of accumulated depreciation of $425,695 and $343,036, respectively	586,932	243,729
Operating lease right of use assets	59,931	5,988
Long-term marketable securities	75,428	495,852
Intangible assets, net	924,603	63,574
Goodwill	1,434,540	197,471
Other assets	78,590	37,323
Deferred income taxes	10,685	48,845
Total assets	$5,086,083	$2,076,126
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$56,671	$36,101
Accrued expenses	240,460	92,169
Operating lease liabilities	11,967	2,536
Income taxes payable	3,845	990
Business acquisition liabilities	61,035	13,308
Deferred revenue	18,369	14,100
Total current liabilities	392,347	159,204
Business acquisition liabilities, net of current portion	78,323	54,950
Operating lease liabilities	91,037	3,475
Senior convertible notes	417,400	—
Deferred income taxes and other tax liabilities	84,421	1,779
Other liabilities	24,596	10,345
Total liabilities	1,088,124	229,753
Commitments and contingencies (Note 16)
Equity:
Class A common stock; $0.001 par value. Authorized 500,000,000 shares; issued and outstanding 113,905,565 and 77,762,282 shares at December 31, 2023 and December 31, 2022, respectively	114	78
Class B common stock; $0.001 par value. Authorized 275,000,000 shares; issued and outstanding 22,430,097 and 22,430,097 shares at December 31, 2023 and December 31, 2022, respectively	22	22
Additional paid-in capital	2,870,749	630,952
Accumulated other comprehensive income/(loss)	(10,192)	(24,630)
Retained earnings	1,137,266	1,239,951
Total equity	3,997,959	1,846,373
Total liabilities and equity	$5,086,083	$2,076,126

‎

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.